PyInvesting

Market research

GV.PA Genomic Vision Société Anonyme

PA EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
693K
P/E ratio
Not available
Analyst target
0.2
Dividend yield
Not available
Beta
-0.67

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Genomic Vision Société Anonyme is currently in a long term downtrend where the price is trading 38.4% below its 200 day moving average.

From a valuation standpoint, the stock is 94.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.9.

Based on the above factors, Genomic Vision Société Anonyme gets an overall score of 1/5.